Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Core Laboratories (CLB) EBT Margin (2022 - 2025)

Core Laboratories' EBT Margin history spans 4 years, with the latest figure at 9.56% for Q4 2025.

  • For Q4 2025, EBT Margin rose 63.0% year-over-year to 9.56%; the TTM value through Dec 2025 reached 8.72%, down 9.0%, while the annual FY2025 figure was 8.72%, 10.0% down from the prior year.
  • EBT Margin reached 9.56% in Q4 2025 per CLB's latest filing, down from 13.59% in the prior quarter.
  • In the past five years, EBT Margin ranged from a high of 13.59% in Q3 2025 to a low of 1.47% in Q1 2025.
  • Average EBT Margin over 4 years is 8.54%, with a median of 9.19% recorded in 2023.
  • Peak YoY movement for EBT Margin: soared 485bps in 2023, then tumbled -247bps in 2025.
  • A 4-year view of EBT Margin shows it stood at 9.83% in 2022, then fell by -13bps to 8.55% in 2023, then increased by 4bps to 8.93% in 2024, then grew by 7bps to 9.56% in 2025.
  • Per Business Quant, the three most recent readings for CLB's EBT Margin are 9.56% (Q4 2025), 13.59% (Q3 2025), and 9.67% (Q2 2025).